ELIXIRON IMMUNOTHERAPEUTICS INC.
Update：2023/06/12
Industries
Main Industry
Biotechnology
Main Product/Service
Develop innovative therapies for cancer and immunological diseases.
Founded Year
2017
Unified Business No.
52625245
Status
Active
Number of Employees
0
Total Paid-in
Capital
621,180,000 (NT$)
Location of Company
Taiwan
, Taipei City
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, MOE."
Exclusive content for members
Members-only content. Please log in to access.
Introduction
Elixiron Immunotherapeutics employs advances in translational medicine to identify targets from clinical observations, and various drug modalities including biologics from phage display and single human B cell cloning platforms, to develop innovative therapies for cancer and immunological diseases.
